358 related articles for article (PubMed ID: 16472263)
21. Clinical and pharmacoeconomic profile of COPD patients with FEV1 50--60% predicted: pilot study on the impact of the extended indication of ICS/LABA.
Dal Negro RW; Bonadiman L; Turati C; Turco P
Ther Adv Respir Dis; 2009 Apr; 3(2):51-8. PubMed ID: 19443518
[TBL] [Abstract][Full Text] [Related]
22. A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD.
Fromer L; Cooper CB
Int J Clin Pract; 2008 Aug; 62(8):1219-36. PubMed ID: 18547365
[TBL] [Abstract][Full Text] [Related]
23. Influenza vaccination among Canadians with chronic respiratory disease.
Vozoris NT; Lougheed MD
Respir Med; 2009 Jan; 103(1):50-8. PubMed ID: 18818066
[TBL] [Abstract][Full Text] [Related]
24. Preventing chronic obstructive pulmonary disease: what is known and what needs to be done to make a difference to the patient?
Wise RA; Tashkin DP
Am J Med; 2007 Aug; 120(8 Suppl 1):S14-22. PubMed ID: 17678939
[TBL] [Abstract][Full Text] [Related]
25. Chronic respiratory symptoms, spirometry and knowledge of COPD among general population.
Miravitlles M; de la Roza C; Morera J; Montemayor T; Gobartt E; Martín A; Alvarez-Sala JL
Respir Med; 2006 Nov; 100(11):1973-80. PubMed ID: 16626950
[TBL] [Abstract][Full Text] [Related]
26. Part I: Identifying chronic obstructive pulmonary disease in patients with respiratory symptoms.
Sussman R
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S5-12. PubMed ID: 17925063
[TBL] [Abstract][Full Text] [Related]
27. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease.
Shirtcliffe P; Marsh S; Travers J; Weatherall M; Beasley R
Intern Med J; 2012 Jan; 42(1):83-8. PubMed ID: 20403069
[TBL] [Abstract][Full Text] [Related]
28. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
Akazawa M; Biddle AK; Stearns SC
Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
[TBL] [Abstract][Full Text] [Related]
29. Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population.
Johannessen A; Omenaas E; Bakke P; Gulsvik A
Int J Tuberc Lung Dis; 2005 Aug; 9(8):926-32. PubMed ID: 16104642
[TBL] [Abstract][Full Text] [Related]
30. Office management of COPD in primary care: a 2009 clinical update.
Belfer MH
Postgrad Med; 2009 Jul; 121(4):82-90. PubMed ID: 19641274
[TBL] [Abstract][Full Text] [Related]
31. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
Gershon AS; Wang L; To T; Luo J; Upshur RE
COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
[TBL] [Abstract][Full Text] [Related]
32. Are patient characteristics helpful in recognizing mild COPD (GOLD I) in daily practice?
Geijer RM; Sachs AP; Verheij TJ; Lammers JW; Salomé PL; Hoes AW
Scand J Prim Health Care; 2006 Dec; 24(4):237-42. PubMed ID: 17118864
[TBL] [Abstract][Full Text] [Related]
33. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
34. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
Buyukkaplan US; Akkaya A; Yildiz M; Bircan A; Aksoy Dogan A; Ozturk O
J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
[TBL] [Abstract][Full Text] [Related]
35. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study.
Montes de Oca M; Tálamo C; Perez-Padilla R; Jardim JR; Muiño A; Lopez MV; Valdivia G; Pertuzé J; Moreno D; Halbert RJ; Menezes AM;
Respir Med; 2008 May; 102(5):642-50. PubMed ID: 18314321
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of chronic obstructive pulmonary disease in Cyprus: a population-based study.
Zachariades AG; Zachariadou T; Adamide T; Anagnostopoulou U; Georgiou A; Gourgoulianis KI
COPD; 2012 Jun; 9(3):259-67. PubMed ID: 22432899
[TBL] [Abstract][Full Text] [Related]
37. Early detection of COPD: a case finding study in general practice.
Vandevoorde J; Verbanck S; Gijssels L; Schuermans D; Devroey D; De Backer J; Kartounian J; Vincken W
Respir Med; 2007 Mar; 101(3):525-30. PubMed ID: 16908127
[TBL] [Abstract][Full Text] [Related]
38. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM
Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
[TBL] [Abstract][Full Text] [Related]
39. Maintenance pharmacotherapy of mild and moderate COPD: what is the evidence?
Ferguson GT
Respir Med; 2011 Sep; 105(9):1268-74. PubMed ID: 21353516
[TBL] [Abstract][Full Text] [Related]
40. Practical management problems of stable chronic obstructive pulmonary disease in the elderly.
Pistelli R; Ferrara L; Misuraca C; Bustacchini S
Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S43-8. PubMed ID: 22209930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
